1. Home
  2. ELME vs VYGR Comparison

ELME vs VYGR Comparison

Compare ELME & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elme Communities

ELME

Elme Communities

N/A

Current Price

$2.09

Market Cap

198.2M

Sector

Real Estate

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$4.87

Market Cap

194.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELME
VYGR
Founded
1960
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
194.0M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
ELME
VYGR
Price
$2.09
$4.87
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$12.67
$17.00
AVG Volume (30 Days)
1.1M
724.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
33.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$206,360,000.00
$10,135,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$71.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.10
$2.65
52 Week High
$17.68
$5.55

Technical Indicators

Market Signals
Indicator
ELME
VYGR
Relative Strength Index (RSI) 12.30 69.35
Support Level $2.10 $3.84
Resistance Level $2.26 N/A
Average True Range (ATR) 0.04 0.29
MACD 0.22 0.13
Stochastic Oscillator 13.64 84.81

Price Performance

Historical Comparison
ELME
VYGR

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: